Seely Lynn sold LYEL
February 10, 2026 · Form 4 insider transaction
Seely Lynn sold 438 shares of Lyell Immunopharma, Inc. at $23.12 per share, a transaction worth $10.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
438
Price
$23.12
Total value
$10.1K
InsiderSeely Lynn
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 10, 2026
Filing dateFebruary 11, 2026
Shares owned after81,721
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.